Shortage of key TB drug stress patients; activists urge govt to issue compulsory license, Health News, ET HealthWorld
MUMBAI: Stockouts are being reported across the country of a key patented drug, Delaminid, used in drug-resistant tuberculosis (DR-TB), hampering the government’s goal of TB elimination and causing hardship to…
